Tert-butyl N-[(3R)-3-[2-(2-fluorophenyl)-6-(oxolan-2-yl)imidazo[4,5-c]pyridin-1-yl]cyclohexyl]carbamate
C27H33FN4O3 — CID 168885520
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[(3R)-3-[2-(2-fluorophenyl)-6-(oxolan-2-yl)imidazo[4,5-c]pyridin-1-yl]cyclohexyl]carbamate
Tert-butyl N-[(3R)-3-[2-(2-fluorophenyl)-6-(oxolan-2-yl)imidazo[4,5-c]pyridin-1-yl]cyclohexyl]carbamate (PubChem CID 168885520) has the molecular formula C27H33FN4O3 and a molecular weight of 480.58 g/mol. Its IUPAC name is tert-butyl N-[(3R)-3-[2-(2-fluorophenyl)-6-(oxolan-2-yl)imidazo[4,5-c]pyridin-1-yl]cyclohexyl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[(3R)-3-[2-(2-fluorophenyl)-6-(oxolan-2-yl)imidazo[4,5-c]pyridin-1-yl]cyclohexyl]carbamate |
|---|---|
| PubChem CID | 168885520 |
| Molecular Formula | C27H33FN4O3 |
| Molecular Weight | 480.58 g/mol |
| Exact Mass | 480.25 |
| IUPAC Name | tert-butyl N-[(3R)-3-[2-(2-fluorophenyl)-6-(oxolan-2-yl)imidazo[4,5-c]pyridin-1-yl]cyclohexyl]carbamate |
| SMILES | CC(C)(C)OC(=O)NC1CCC[C@@H](n2c(-c3ccccc3F)nc3cnc(C4CCCO4)cc32)C1 |
| InChI | InChI=1S/C27H33FN4O3/c1-27(2,3)35-26(33)30-17-8-6-9-18(14-17)32-23-15-21(24-12-7-13-34-24)29-16-22(23)31-25(32)19-10-4-5-11-20(19)28/h4-5,10-11,15-18,24H,6-9,12-14H2,1-3H3,(H,30,33)/t17?,18-,24?/m1/s1 |
| InChIKey | IBYFQEAMPKARRF-RKDDFOCISA-N |
| XLogP | 6.10 |
| TPSA | 78.27 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 480.58 |
| LogP ≤ 5 | 6.10 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168885520 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.